Nathan Smith

661 citations

16 papers · 508 indexed · h-index 12

Co-authors: Benson Edagwa JoEllyn McMillan Howard E. Gendelman Yazen Alnouti Shantanu Balkundi Nagsen Gautam Xin-Ming Liu Upal Roy
Topics: HIV Research and Treatment (8 papers)HIV/AIDS drug development and treatment (7 papers)HIV/AIDS Research and Interventions (6 papers)
Cited by: Virology Infectious Diseases Pharmaceutical Science
Journals: Proceedings of the National Academy of Sciences Nature Communications Biomaterials
Partner nations: United States Italy China

In The Last Decade

Nathan Smith

14 papers receiving 501 citations

Peers

Countries citing papers authored by Nathan Smith

Since Specialization

Citations

This map shows the geographic impact of Nathan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Smith more than expected).

Fields of papers citing papers by Nathan Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Smith. The network helps show where Nathan Smith may publish in the future.

Co-authorship network of co-authors of Nathan Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Smith. A scholar is included among the top collaborators of Nathan Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Smith. Nathan Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Conserved C143 forms a branched intermediate in Hedgehog autoprocessing: A cancer drug discovery target against Hedgehog signaling 2025 ·Proceedings of the National Academy of Sciences ·(unknown),Ke Xia,(unknown),Zihan Xu,Nathan Smith,José‐Luis Giner,Brian P. Callahan,Jian Xie,Chunyu Wang	0
2	Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease 2024 ·Acta Biomaterialia ·Wei Zhang,Nathan Smith,(unknown),(unknown),Mattia Bartoli,(unknown),Jiuyan Chen,Justin B. Domena,(unknown),(unknown),Guohua Lv,(unknown),(unknown),(unknown),Alberto Tagliaferro,David Eliezer,Eduardo A. Véliz,Fuwu Zhang,Chunyu Wang,Roger M. Leblanc	9
3	Development of Diverse Carbon Dots to Inhibit Protein Aggregation in Alzheimer’s Disease 2024 ·Alzheimer s & Dementia ·Nathan Smith,(unknown),Wei Zhang,Chunyu Wang	0
4	Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin D 2022 ·Journal of Molecular Biology ·Jing Zhao,Xinyue Liu,(unknown),Yumeng Zhang,(unknown),(unknown),Nathan Smith,Fuming Zhang,Robert J. Linhardt,Jianhan Chen,Christopher Baines,Stewart N. Loh,Chunyu Wang	14
5	Small-molecule compound from AlphaScreen disrupts tau-glycan interface 2022 ·Frontiers in Molecular Biosciences ·(unknown),Weihua Jin,James M. Gibson,(unknown),Nathan Smith,Peng He,Fuming Zhang,Robert J. Linhardt,Chunyu Wang	2
6	Drug delivery of memantine with carbon dots for Alzheimer’s disease: blood–brain barrier penetration and inhibition of tau aggregation 2022 ·Journal of Colloid and Interface Science ·Wei Zhang,(unknown),Yiqun Zhou,Nathan Smith,Braulio C.L.B. Ferreira,(unknown),(unknown),Keenan J. Mintz,Chunyu Wang,Roger M. Leblanc	64
7	Structure-activity relationship of carbon nitride dots in inhibiting Tau aggregation 2022 ·Carbon ·Yiqun Zhou,(unknown),Mattia Bartoli,(unknown),Ahmed E. ElMetwally,(unknown),(unknown),(unknown),Nathan Smith,Elisa Padovano,Wei Zhang,Keenan J. Mintz,Braulio C.L.B. Ferreira,(unknown),Jiuyan Chen,Sujit Kumar Shah,Rajeev Prabhakar,Alberto Tagliaferro,Chunyu Wang,Roger M. Leblanc	29
8	Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles 2021 ·Nature Communications ·(unknown),Nathan Smith,(unknown),Aditya N. Bade,Nagsen Gautam,Bhagya Laxmi Dyavar Shetty,JoEllyn McMillan,Yazen Alnouti,Samuel M. Cohen,Howard E. Gendelman,Benson Edagwa	36
9	Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research 2020 ·Expert Opinion on Drug Delivery ·(unknown),Nathan Smith,Benson Edagwa,JoEllyn McMillan	47
10	A long acting nanoformulated lamivudine ProTide 2019 ·Biomaterials ·Nathan Smith,Aditya N. Bade,Dhruvkumar Soni,Nagsen Gautam,Yazen Alnouti,Jonathan Herskovitz,Ibrahim M. Ibrahim,Melinda Wojtkiewicz,Bhagya Laxmi Dyavar Shetty,JoEllyn McMillan,Howard E. Gendelman,Benson Edagwa	28
11	Optimizing the Preparation and Stability of Decorated Antiretroviral Drug Nanocrystals 2018 ·Nanomedicine ·Tianhua Zhou,Zhiyi Lin,(unknown),(unknown),James R. Hilaire,Mariluz Araínga,Nathan Smith,Nagsen Gautam,JoEllyn McMillan,Yazen Alnouti,Xinming Liu,Benson Edagwa,Howard E. Gendelman	21
12	Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections 2013 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown),JoEllyn McMillan,(unknown),(unknown),Shantanu Balkundi,Nathan Smith,(unknown),Benson Edagwa,Alexander V. Kabanov,Tatiana K. Bronich,Howard E. Gendelman,Xin-Ming Liu	70
13	Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy 2013 ·Antimicrobial Agents and Chemotherapy ·Nagsen Gautam,Upal Roy,Shantanu Balkundi,(unknown),Dongwei Guo,Nathan Smith,Xin-Ming Liu,Benjamin G. Lamberty,Brenda Morsey,Howard S. Fox,JoEllyn McMillan,Howard E. Gendelman,Yazen Alnouti	65
14	Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya 2012 ·Malaria Journal ·(unknown),Nathan Smith,Diana Menya,Andrew Obala,Chrispinus J Simiyu,Barasa Khwa-Otsyula,Wendy Prudhomme O’Meara	17
15	Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1–Infected Human Peripheral Blood Lymphocyte–Reconstituted Mice 2012 ·The Journal of Infectious Diseases ·Upal Roy,JoEllyn McMillan,Yazen Alnouti,(unknown),Nathan Smith,Shantanu Balkundi,Prasanta K. Dash,Santhi Gorantla,(unknown),Jane L. Meza,Georgette D. Kanmogne,Susan Swindells,Samuel M. Cohen,R. Lee Mosley,Larisa Y. Poluektova,Howard E. Gendelman	51
16	Molecular modeling studies of HIV‐1 reverse transcriptase nonnucleoside inhibitors: Total energy of complexation as a predictor of drug placement and activity 1995 ·Protein Science ·Marilyn B. Kroeger Smith,Stephen H. Hughes,Paul L. Boyer,Christopher J. Michejda,Carol A. Rouzer,Lisa A. Taneyhill,Richard H. Smith,Nathan Smith,(unknown),(unknown),Luc Koymans,Eddy Arnold,(unknown),Kalyan Das,Wanyi Zhang	55

About Nathan Smith

Nathan Smith is a scholar working on Virology, Infectious Diseases and Physiology, having authored 16 papers that have together received 508 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). The work is most often cited by research in Virology (218 citations), Infectious Diseases (236 citations) and Pharmaceutical Science (43 citations). Nathan Smith has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Benson Edagwa, JoEllyn McMillan, Howard E. Gendelman, Yazen Alnouti, Shantanu Balkundi, Nagsen Gautam, Xin-Ming Liu, JoEllyn McMillan, Upal Roy and Keenan J. Mintz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact